PMID: 2113313Jan 1, 1990Paper

Blood coagulation alterations after embolic occlusion of the renal circulation

Scandinavian Journal of Urology and Nephrology
S TörngrenC R Nyman

Abstract

Alterations in blood coagulation and fibrinolysis after embolic occlusion of renal adenocarcinoma were investigated in 11 patients. Peripheral vein blood was collected before, 2 hours after and on the first, third and fifth to seventh day after embolization. Five patients had renal vein blood sampling before and 2 hours after embolization. Increased levels of fibrinogen, plasminogen and antiplasmin were found on days 1-3. Antithrombin III showed a slight decrease between days 1 and 3 after embolization. All measured variables were lower in renal vein compared with simultaneous samples from peripheral vein. In renal vein samples, consumption of antiplasmin and antikallikrein was indicated. Fibrinopeptide A (FPA) was increased, with a mean maximum 2 hours after embolization. The findings seemed mainly to monitor acute phase reaction but also activation of blood coagulation and fibrinolysis. Embolization might be used as a human model of coagulation activation and acute phase reaction.

References

Sep 1, 1979·The Journal of Clinical Investigation·D F Mosher, P E Schad
Sep 1, 1977·Scandinavian Journal of Clinical and Laboratory Investigation·A C Teger-NilssonE Gyzander
Jan 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·C B Laurell
Oct 1, 1973·British Journal of Urology·L E AlmgårdA Ljungqvist
Jan 1, 1984·Progress in Clinical and Biological Research·K H KurthC C Schulman
Jan 1, 1983·European Urology·A V Bono, A Caresano
Jan 1, 1981·Urologic Radiology·V P ChuangD A Swanson
May 1, 1963·Clinica Chimica Acta; International Journal of Clinical Chemistry·C VERMYLENM VERSTRAETE

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.